Bihua Chen - Insider Trading & Ownership

Location
C/O Cormorant Asset Management, Lp, 200 Clarendon Street, 52 Nd Floor, Boston, MA
Summary
The estimated net worth of Bihua Chen is at least $229M dollars as of October 1, 2025. Bihua Chen is the Director, 10%+ Owner of BridgeBio Oncology Therapeutics, Inc. and owns shares of Helix Acquisition Corp. II (HLXB) stock worth about $192M. Bihua Chen is the Director of Erasca, Inc. and owns shares of Erasca, Inc. (ERAS) stock worth about $17.2M. Bihua Chen is the Former 10% Owner of MoonLake Immunotherapeutics and owns shares of MoonLake Immunotherapeutics (MLTX) stock worth about $13.9M. Bihua Chen is the Former Director of Biomea Fusion, Inc. and owns shares of Biomea Fusion, Inc. (BMEA) stock worth about $5.97M.
Signature
/s/ Bihua Chen
All Insider Reports
All Insider Reports

Ownership of Bihua Chen

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
HLXB Helix Acquisition Corp. II Director, 10%+ Owner $192M Aug 11, 2025
ERAS Erasca, Inc. Director $17.2M Jun 22, 2023
MLTX MoonLake Immunotherapeutics Former 10% Owner $13.9M -$46.9M -77.2% Sep 29, 2025
BMEA Biomea Fusion, Inc. Former Director $5.97M Aug 1, 2025

Insider Transactions Reported by Bihua Chen:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.